H.Res. 803 · 119th Congress

Urging the Director of the Food and Drug Administration to reevaluate the safety of all chemical abortion drugs in light of recent independent studies, and for other purposes.

Stage
In committee
Sponsor
John Rose
Introduced
2025-10-10
Latest action
2025-10-10 · Submitted in House

Subjects

Health